Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2014470117Source: DataRank Database

Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma is a research paper published in Proceedings of the National Academy of Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.60)OA: greenTopics (79)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Wei Wei ORCID,Wenming Xiao ORCID,Essel Dulaimi Al-Saleem,Reza Nejati ORCID,Liqi Chen ORCID

Live enrichment

PubMed:33139544 PMC:PMC7682429 OpenAlex:https://openalex.org/W3096310372

NIH

Grant: K22CA197014

American Cancer Society

Grant: IRG-92-027-21

Medical Research Grant from the W. W. SMITH Charitable Trust

Grant: N/A

Intramural Research Program Clinical Cancer Research National Cancer Institute NiH

Grant: ZIA SC 004002

NCI NIH HHS

Grant: P30 CA006927

National Institutes of Health

Grant: 1K22CA197014-01

Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma

National Institutes of Health

Grant: 5P30CA006927-49

Transgenic Mouse

FWCI

1.60

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.pnas.org/site/aboutpnas/licenses.xhtml

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7682429

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2014470117

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2014470117

journalhttps://doi.org/10.1073/pnas.2014470117

Fields of Study

Lymphoma Diagnosis and TreatmentNF-κB Signaling PathwaysUbiquitin and proteasome pathways0301 basic medicine03 medical and health sciencesAnimalsCell Line, TumorDisease Models, AnimalFemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHeterograftsHodgkin DiseaseHumansIntracellular Signaling Peptides and ProteinsMAP Kinase Kinase KinasesMiceNF-kappa BProtein BindingSignal TransductionTumor Necrosis Factor alpha-Induced Protein 3UbiquitinUbiquitinationMAP Kinase Kinase Kinase 7

MeSH Terms

Tumor Necrosis Factor alpha-Induced Protein 3MAP Kinase Kinase Kinase 7AnimalsDisease Models, AnimalFemaleHodgkin DiseaseHumansProtein BindingSignal TransductionGene Expression Regulation, NeoplasticGenes, Tumor SuppressorNF-kappa BMAP Kinase Kinase KinasesUbiquitinCell Line, TumorIntracellular Signaling Peptides and ProteinsMiceUbiquitinationHeterografts

Keywords

UbiquitinMutantUbiquitin ligaseLymphomaHodgkin lymphomaKinaseUbiquitin-Protein LigasesMutationChain (unit)BiologyCell biologyCancer researchGeneticsComputational biologyGeneImmunologyUbiquitinationNF-KBsignaling transductionIntracellular Signaling Peptides and ProteinsNF-kappa BMAP Kinase Kinase KinasesHodgkin DiseaseMAP Kinase Kinase Kinase 7Gene Expression Regulation, NeoplasticDisease Models, AnimalMiceCell Line, TumorAnimalsHeterograftsHumansFemaleGenes, Tumor SuppressorTumor Necrosis Factor alpha-Induced Protein 3Protein BindingSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being